- Home
- ASBP vs HODO Comparison
ASBP vs HODO Comparison
Compare ASBP & HODO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$8.78
HOLD
Current Price
$0.07
Company Overview
Basic Information| Metric | ASBP | HODO |
|---|---|---|
| Founded | 2021 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4M | 10.3M |
| IPO Year | 2021 | 2024 |
Fundamental Metrics
Financial Performance| Metric | ASBP | HODO |
|---|---|---|
| Price | $8.78 | $0.07 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 28.2K | ★ 16.8M |
| Earning Date | 11-13-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | ★ $105.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $1.37 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.31 | $0.05 |
| 52 Week High | $367.50 | $2.52 |
Technical Indicators
Market Signals| Indicator | ASBP | HODO |
|---|---|---|
| Relative Strength Index (RSI) | 54.82 | 20.66 |
| Support Level | $7.88 | $0.05 |
| Resistance Level | $9.27 | $0.20 |
| Average True Range (ATR) | 0.64 | 0.02 |
| MACD | 0.05 | 0.01 |
| Stochastic Oscillator | 86.28 | 16.13 |
Price Performance
Historical Comparison ASBP
HODO
About ASBP Aspire Biopharma Holdings Inc.
Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.